By: Peter Davido
Photo Credit: The Defeating Epilepsy Foundation
The Relationship Between Seizures and Depression
Abstract
Depression is one of the most common psychiatric comorbidities associated with epilepsy and seizure disorders. Research has consistently demonstrated a strong and complex relationship between seizures and depression, involving biological, psychological, and social factors. The mechanisms underlying this association, including shared neurobiological pathways, psychosocial stressors, and medication effects. Additionally, the bidirectional nature of this relationship will be explored, in which depression can increase seizure risk while seizures can contribute to the development of depressive symptoms. Understanding this relationship is critical for improving treatment outcomes and quality of life among individuals living with epilepsy.
Introduction
Epilepsy is a chronic neurological condition characterized by recurrent, unprovoked seizures. It affects millions of individuals worldwide and is frequently accompanied by psychiatric comorbidities, particularly depression. Depression is significantly more prevalent in individuals with epilepsy compared to the general population, with estimates suggesting that approximately 23% to 34% of individuals with epilepsy experience depressive symptoms (Fiest et al., 2013; Qin et al., 2022). This high comorbidity highlights an important clinical issue, as untreated depression negatively impacts quality of life, treatment adherence, and seizure outcomes (Mula & Schmitz, 2009).
The relationship between seizures and depression is multifaceted and cannot be attributed to a single cause. Instead, it involves an interaction of neurological, psychological, and environmental factors. This paper explores these contributing elements and emphasizes the importance of integrated care for individuals with both conditions.
Biological and Neurological Mechanisms
One of the key explanations for the link between seizures and depression lies in shared neurobiological processes. Both conditions involve dysregulation of neurotransmitters such as serotonin, dopamine, and gamma‑aminobutyric acid (GABA), which play essential roles in mood regulation and neuronal excitability (Shi et al., 2025). Disruptions in these systems can predispose individuals to both seizures and depressive symptoms.
Additionally, structural and functional abnormalities in specific brain regions contribute to this association. The temporal lobe, which is commonly involved in epilepsy, is also critical for emotional processing. Depression has been frequently observed in individuals with temporal lobe epilepsy, suggesting a direct neurological link between seizure activity and mood disorders (Garcia, 2012). Changes such as hippocampal atrophy have been observed in patients with both epilepsy and depression, further supporting a shared biological basis (Shamim et al., 2009). Inflammation and neuroendocrine dysregulation have also been implicated. Emerging evidence indicates that inflammatory processes and oxidative stress may contribute to both seizure activity and depressive symptoms (Shi et al., 2025).
Psychological and Social Factors
Beyond biological mechanisms, psychological and social factors play a significant role in the development of depression among individuals with seizures. Living with epilepsy can involve considerable emotional stress due to the unpredictability of seizures, fear of injury, and social stigma. These stressors can lead to chronic anxiety, reduced self-esteem, and feelings of helplessness (Mula & Schmitz, 2009). Individuals with epilepsy may also face limitations in employment, driving, and social participation, which can contribute to isolation and decreased quality of life. These psychosocial challenges are strongly associated with depressive symptoms and may exacerbate the overall burden of the disease (Qin et al., 2022).
Medication and Treatment Considerations
Antiepileptic drugs (AEDs), while essential for seizure control, may also influence mood. Some medications have been associated with depressive side effects, while others may stabilize mood. The relationship between AEDs and depression is complex and varies depending on the specific medication and individual patient factors (Mula & Schmitz, 2009).
Furthermore, interactions between antidepressants and antiepileptic medications must be carefully managed. Certain antidepressants can affect seizure threshold, making treatment decisions more challenging (Miziak et al., 2022). As a result, clinicians must adopt a balanced approach when treating patients with comorbid epilepsy and depression.
Bidirectional Relationship Between Seizures and Depression
A critical aspect of the relationship between seizures and depression is its bidirectional nature. Not only do seizures increase the risk of depression, but depression itself has been shown to increase the likelihood of developing epilepsy and worsen seizure outcomes (Josephson et al., 2017). Large cohort studies have demonstrated that individuals with depression have a significantly higher risk of developing epilepsy, while those with epilepsy have an increased risk of developing depression over time (Munger Clary, 2023). Additionally, depression may increase seizure frequency and severity, possibly due to stress, sleep disturbances, and neuroendocrine changes (Shi et al., 2025). This bidirectional relationship creates a cycle in which each condition exacerbates the other, making early identification and treatment of both disorders essential.
Implications for Treatment
Given the strong association between seizures and depression, an integrated treatment approach is necessary. Effective management should include regular screening for depression in individuals with epilepsy, as well as coordinated care between neurologists and mental health professionals (Fiest et al., 2013). Psychological interventions, such as cognitive behavioral therapy (CBT), have shown effectiveness in reducing depressive symptoms and improving quality of life. Pharmacological treatment must be carefully tailored to avoid adverse interactions and optimize both seizure control and mood stabilization (Miziak et al., 2022).
Addressing lifestyle factors, including stress management, sleep hygiene, and social support, is also crucial for improving outcomes. Comprehensive care can significantly enhance both mental health and seizure control.
Conclusion
The relationship between seizures and depression is complex and multifactorial, involving biological, psychological, and social components. The shared neurobiological mechanisms, combined with the psychosocial challenges of living with epilepsy, contribute to the high prevalence of depression in this population. Additionally, the bidirectional nature of this relationship underscores the importance of treating both conditions simultaneously. Improved awareness, early detection, and integrated treatment strategies are essential for enhancing patient outcomes. Future research should continue to explore the mechanisms underlying this relationship and develop targeted interventions to address both neurological and psychiatric aspects of epilepsy.
References
Fiest, K. M., Dykeman, J., Patten, S. B., Wiebe, S., Kaplan, G. G., Maxwell, C. J., Bulloch, A. G. M., & Jetté, N. (2013). Depression in epilepsy: A systematic review and meta-analysis. Neurology, 80(6), 590–599. https://doi.org/10.1212/WNL.0b013e31827b1ae0
Garcia, C. S. (2012). Depression in temporal lobe epilepsy: A review of prevalence, clinical features, and management considerations. Epilepsy Research and Treatment, 2012, 809843. https://doi.org/10.1155/2012/809843
Josephson, C. B., Lowerison, M., Vallerand, I., Sajobi, T. T., Patten, S. B., Jetté, N., & Wiebe, S. (2017). Association of depression with epilepsy and seizure outcomes: A multicohort analysis. JAMA Neurology, 74(5), 533–539. https://doi.org/10.1001/jamaneurol.2016.5042
Miziak, B., Czuczwar, S. J., & Pluta, R. (2022). Comorbid epilepsy and depression—Pharmacokinetic and pharmacodynamic drug interactions. Frontiers in Pharmacology, 13, 988716. https://doi.org/10.3389/fphar.2022.988716
Mula, M., & Schmitz, B. (2009). Depression in epilepsy: Mechanisms and therapeutic approach. Therapeutic Advances in Neurological Disorders, 2(5), 337–344. https://doi.org/10.1177/1756285609337340
Munger Clary, H. M. (2023). Depression and epilepsy: The bidirectional relation goes on and on. Epilepsy Currents, 23(4), 222–224. https://doi.org/10.1177/15357597231169553
Qin, S.-K., Yang, Z.-X., Guan, Z.-W., Zhang, J.-H., Ping, X., Lu, Y., & Pei, L. (2022). Exploring the association between epilepsy and depression: A systematic review and meta-analysis. PLOS ONE, 17(12), e0278907. https://doi.org/10.1371/journal.pone.0278907
Shamim, S., Hasler, G., Liew, C., Sato, S., & Theodore, W. H. (2009). Temporal lobe epilepsy, depression, and hippocampal volume. Epilepsia, 50(5), 1067–1071. https://doi.org/10.1111/j.1528-1167.2008.01883.x
Shi, Y.-Q., Yang, H.-C., He, C., Wang, Y.-H., Zheng, J., Wang, X.-Y., Hao, F.-Y., Feng, C.-W., Ma, L., & Zhang, Y.-H. (2025). Inflammatory links between epilepsy and depression: A review of mechanisms and therapeutic strategies. Frontiers in Neuroscience, 19, 1614297. https://doi.org/10.3389/fnins.2025.1614297
